Zilver PTX Post-Market Study in Japan

N/ACompletedNCT02254837

Cook Group Incorporated909 enrolled

Overview

Japanese post market clinical study of the Zilver PTX device.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

909

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Symptomatic peripheral arterial disease (PAD) involving the above-the-knee femoropopliteal arteries

Occurrence of stent fracture

Time frame: 5 years

Rate of adverse events

Time frame: 5 years

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.